Mckesson Corporation risk profile
45 Elevated one input has moved against it
Measured 21 October 2026 from MCK's filed statements. Recomputed nightly.
45 (Elevated), driven by Concentration at 66, over 7 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 19 | Contained | Stable | One-year price volatility — 30.2% |
| Operating pressure | 41 | Elevated | Stable | Costs outgrowing revenue — -0.3 percentage points |
| Cash conversion | 38 | Normal | Worsening | Free-cash-flow margin — 1.4% |
| Leverage and coverage | 19 | Contained | Stable | Current ratio — 0.85x |
| Competitive position | 40 | Elevated | Stable | Operating-margin gap against peers — -3.4 percentage points |
| Concentration | 66 | Stretched | Stable | Supplier concentration — 5,245 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 33Johnson & Johnson 39Abbvie Inc 57Unitedhealth Group Inc 43Roche Holding AG 35Merck & Co Inc 35Novartis AG 29Novartis AG 31Astrazeneca plc 33Thermo Fisher Scientific Inc 44AMGEN Inc 47Gilead Sciences Inc 51
Financials, valuation and price history for Mckesson Corporation